131 related articles for article (PubMed ID: 32584160)
1. Uncovering the underhanded: B-cell depletion therapies and severe viral infections - Commentary on 'Fatal underhanded chronic enterovirus infection associated with anti-CD20 monotherapy for central nervous system demyelinating disease'.
Tanasescu R; Gran B
Mult Scler; 2021 Feb; 27(2):323-324. PubMed ID: 32584160
[No Abstract] [Full Text] [Related]
2. Fatal underhanded chronic enterovirus infection associated with anti-CD20 monotherapy for central nervous system demyelinating disease.
Luciani L; Ninove L; Zandotti C; Chalvignac V; Lagier D; Baume J; Mélade J; Piorkowski G; Coutard B; Lepidi H; Pelletier J; Audoin B; Rico-Lamy A; Nougairède A
Mult Scler; 2021 Feb; 27(2):320-323. PubMed ID: 32584194
[TBL] [Abstract][Full Text] [Related]
3. B cell depleting therapy for multiple sclerosis overlapping with neuromyelitis optica spectrum disorder.
Lu T; Shu Y; Dai Y; Liu X; Chang Y; Huang Q; Kermode AG; Qiu W
Mult Scler Relat Disord; 2018 May; 22():83-85. PubMed ID: 29621743
[TBL] [Abstract][Full Text] [Related]
4. The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related Disorders.
Häusser-Kinzel S; Weber MS
Front Immunol; 2019; 10():201. PubMed ID: 30800132
[TBL] [Abstract][Full Text] [Related]
5. Peripheral CD19
Ellrichmann G; Bolz J; Peschke M; Duscha A; Hellwig K; Lee DH; Linker RA; Gold R; Haghikia A
J Neurol; 2019 Jan; 266(1):57-67. PubMed ID: 30377816
[TBL] [Abstract][Full Text] [Related]
6. Fatal Enterovirus-related Myocarditis in a Patient with Devic's Syndrome Treated with Rituximab.
Diarra A; Gantois G; Lazrek M; Verdier B; Elsermans V; Zephir H; Longère B; Gkizas X; Goeminne C; Lemesle G; Juthier F; Bene J; Launay D; Dubois R; Morell-Dubois S; Vuotto F; Piton AL
Card Fail Rev; 2021 Mar; 7():e09. PubMed ID: 34035954
[TBL] [Abstract][Full Text] [Related]
7. Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring. A six-year follow-up.
Evangelopoulos ME; Andreadou E; Koutsis G; Koutoulidis V; Anagnostouli M; Katsika P; Evangelopoulos DS; Evdokimidis I; Kilidireas C
J Neurol Sci; 2017 Jan; 372():92-96. PubMed ID: 28017256
[TBL] [Abstract][Full Text] [Related]
8. Individualized B cell-targeting therapy for neuromyelitis optica spectrum disorder.
Kim SH; Hyun JW; Kim HJ
Neurochem Int; 2019 Nov; 130():104347. PubMed ID: 30513364
[TBL] [Abstract][Full Text] [Related]
9. Neuromyelitis optica spectrum disorder with increased aquaporin-4 microparticles prior to autoantibodies in cerebrospinal fluid: a case report.
Bejerot S; Hesselmark E; Mobarrez F; Wallén H; Hietala MA; Nybom R; Wetterberg L
J Med Case Rep; 2019 Jan; 13(1):27. PubMed ID: 30696485
[TBL] [Abstract][Full Text] [Related]
10. Mild COVID-19 infection despite chronic B cell depletion in a patient with aquaporin-4-positive neuromyelitis optica spectrum disorder.
Creed MA; Ballesteros E; Jr LJG; Imitola J
Mult Scler Relat Disord; 2020 Sep; 44():102199. PubMed ID: 32554285
[TBL] [Abstract][Full Text] [Related]
11. Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis.
Wingerchuk DM; Lucchinetti CF
Curr Opin Neurol; 2007 Jun; 20(3):343-50. PubMed ID: 17495631
[TBL] [Abstract][Full Text] [Related]
12. Prolonged Remission in Neuromyelitis Optica Following Cessation of Rituximab Treatment.
Weinfurtner K; Graves J; Ness J; Krupp L; Milazzo M; Waubant E
J Child Neurol; 2015 Sep; 30(10):1366-70. PubMed ID: 25387545
[TBL] [Abstract][Full Text] [Related]
13. Rituximab use in pediatric central demyelinating disease.
Beres SJ; Graves J; Waubant E
Pediatr Neurol; 2014 Jul; 51(1):114-8. PubMed ID: 24768216
[TBL] [Abstract][Full Text] [Related]
14. Rituximab-induced interstitial lung disease in a patient with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder.
Ahn SH; Kim SM; Sung JJ
Mult Scler Relat Disord; 2018 Feb; 20():192-193. PubMed ID: 29414297
[TBL] [Abstract][Full Text] [Related]
15. Neuromyelitis optica.
Matiello M; Jacob A; Wingerchuk DM; Weinshenker BG
Curr Opin Neurol; 2007 Jun; 20(3):255-60. PubMed ID: 17495617
[TBL] [Abstract][Full Text] [Related]
16. Chronic Enterovirus Meningoencephalitis in Prolonged B-Cell Depletion After Rituximab Therapy: Case Report.
Jacksch C; Dargvainiene J; Böttcher S; Diedrich S; Leypoldt F; Stürner K; Berg D; Schäffer E
Neurol Neuroimmunol Neuroinflamm; 2023 Nov; 10(6):. PubMed ID: 37813597
[TBL] [Abstract][Full Text] [Related]
17. Atypical Pediatric Demyelinating Diseases of the Central Nervous System.
Troxell RM; Christy A
Curr Neurol Neurosci Rep; 2019 Nov; 19(12):95. PubMed ID: 31773416
[TBL] [Abstract][Full Text] [Related]
18. The spectrum of neuromyelitis optica.
Wingerchuk DM; Lennon VA; Lucchinetti CF; Pittock SJ; Weinshenker BG
Lancet Neurol; 2007 Sep; 6(9):805-15. PubMed ID: 17706564
[TBL] [Abstract][Full Text] [Related]
19. [Pathogenesis of autoantibodies in demyelinating disorders of the central nervous system].
Tanaka K; Tanaka M
Nihon Rinsho; 2014 Nov; 72(11):2067-72. PubMed ID: 25518394
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology, immunopathogenesis and management of pediatric central nervous system inflammatory demyelinating conditions.
Pohl D
Curr Opin Neurol; 2008 Jun; 21(3):366-72. PubMed ID: 18451724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
